Introducing CLE-905, a Potent Dual M1/M4 Receptor Agonist in Development for Schizophrenia and BPSD
Time: 3:50 pm
day: Conference Day 1 PM
Details:
- Mechanism of Action – discussing the potential contribution of M1 and M4 receptor agonism
- CLE-905 demonstrated dose dependent robust antipsychotic effect in pharmacological models, IND enabling studies ongoing
